nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—Vinca Alkaloids—Vinorelbine—ovarian cancer	0.259	1	CiPCiCtD
Vincristine—Vinorelbine—ovarian cancer	0.197	1	CrCtD
Vincristine—colon cancer—ovarian cancer	0.12	1	CtDrD
Vincristine—TUBB3—ovarian cancer	0.0771	0.887	CbGaD
Vincristine—Vindesine—Vinorelbine—ovarian cancer	0.0463	0.379	CrCrCtD
Vincristine—Vinblastine—Vinorelbine—ovarian cancer	0.0463	0.379	CrCrCtD
Vincristine—Voacamine—Vinorelbine—ovarian cancer	0.0296	0.242	CrCrCtD
Vincristine—ABCB1—ovarian cancer	0.00988	0.114	CbGaD
Vincristine—TUBB8—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB2B—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB6—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB4A—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB3—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB2A—Vinorelbine—ovarian cancer	0.0066	0.0414	CbGbCtD
Vincristine—TUBB4B—Vinorelbine—ovarian cancer	0.00552	0.0346	CbGbCtD
Vincristine—TUBB—Vinorelbine—ovarian cancer	0.00552	0.0346	CbGbCtD
Vincristine—TUBB1—Vinorelbine—ovarian cancer	0.00552	0.0346	CbGbCtD
Vincristine—SLC22A3—Melphalan—ovarian cancer	0.00511	0.032	CbGbCtD
Vincristine—TUBB8—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—TUBB6—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—TUBB2A—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—TUBB3—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—TUBB4A—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—TUBB2B—Paclitaxel—ovarian cancer	0.00464	0.0291	CbGbCtD
Vincristine—RALBP1—Doxorubicin—ovarian cancer	0.00435	0.0273	CbGbCtD
Vincristine—TUBB—Paclitaxel—ovarian cancer	0.00388	0.0243	CbGbCtD
Vincristine—TUBB4B—Paclitaxel—ovarian cancer	0.00388	0.0243	CbGbCtD
Vincristine—TUBB1—Paclitaxel—ovarian cancer	0.00388	0.0243	CbGbCtD
Vincristine—TUBB4A—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—TUBB2B—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—TUBB3—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—TUBB2A—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—TUBB6—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—TUBB8—Docetaxel—ovarian cancer	0.00335	0.021	CbGbCtD
Vincristine—ABCC10—Paclitaxel—ovarian cancer	0.00297	0.0186	CbGbCtD
Vincristine—TUBB4B—Docetaxel—ovarian cancer	0.00281	0.0176	CbGbCtD
Vincristine—TUBB1—Docetaxel—ovarian cancer	0.00281	0.0176	CbGbCtD
Vincristine—TUBB—Docetaxel—ovarian cancer	0.00281	0.0176	CbGbCtD
Vincristine—ABCC10—Docetaxel—ovarian cancer	0.00214	0.0134	CbGbCtD
Vincristine—ABCB11—Paclitaxel—ovarian cancer	0.00161	0.0101	CbGbCtD
Vincristine—ABCC10—Doxorubicin—ovarian cancer	0.0016	0.01	CbGbCtD
Vincristine—ABCG2—Topotecan—ovarian cancer	0.00155	0.0097	CbGbCtD
Vincristine—ABCC1—Epirubicin—ovarian cancer	0.00116	0.00727	CbGbCtD
Vincristine—ABCC1—Paclitaxel—ovarian cancer	0.00114	0.00717	CbGbCtD
Vincristine—ABCC3—Doxorubicin—ovarian cancer	0.00101	0.0063	CbGbCtD
Vincristine—ABCB11—Doxorubicin—ovarian cancer	0.000869	0.00544	CbGbCtD
Vincristine—ABCC2—Paclitaxel—ovarian cancer	0.000848	0.00531	CbGbCtD
Vincristine—ABCC1—Docetaxel—ovarian cancer	0.000828	0.00519	CbGbCtD
Vincristine—ABCC2—Carboplatin—ovarian cancer	0.000798	0.005	CbGbCtD
Vincristine—ABCG2—Paclitaxel—ovarian cancer	0.000766	0.0048	CbGbCtD
Vincristine—ABCG2—Carboplatin—ovarian cancer	0.000721	0.00452	CbGbCtD
Vincristine—ABCC1—Doxorubicin—ovarian cancer	0.000617	0.00387	CbGbCtD
Vincristine—ABCC2—Docetaxel—ovarian cancer	0.000613	0.00384	CbGbCtD
Vincristine—CYP3A7—Paclitaxel—ovarian cancer	0.000566	0.00355	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.000566	0.00355	CbGbCtD
Vincristine—ABCB1—Topotecan—ovarian cancer	0.000558	0.0035	CbGbCtD
Vincristine—ABCG2—Docetaxel—ovarian cancer	0.000554	0.00347	CbGbCtD
Vincristine—ABCC2—Doxorubicin—ovarian cancer	0.000457	0.00286	CbGbCtD
Vincristine—CYP3A5—Paclitaxel—ovarian cancer	0.000425	0.00266	CbGbCtD
Vincristine—ABCG2—Doxorubicin—ovarian cancer	0.000413	0.00259	CbGbCtD
Vincristine—CYP3A7—Docetaxel—ovarian cancer	0.000409	0.00256	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.000409	0.00256	CbGbCtD
Vincristine—ABCB1—Vinorelbine—ovarian cancer	0.000393	0.00246	CbGbCtD
Vincristine—TUBB4B—oviduct—ovarian cancer	0.00036	0.027	CbGeAlD
Vincristine—Vinblastine—NR5A1—ovarian cancer	0.000335	0.371	CrCbGaD
Vincristine—CYP3A4—Topotecan—ovarian cancer	0.000334	0.00209	CbGbCtD
Vincristine—CYP3A5—Docetaxel—ovarian cancer	0.000307	0.00192	CbGbCtD
Vincristine—ABCB1—Paclitaxel—ovarian cancer	0.000276	0.00173	CbGbCtD
Vincristine—Vinorelbine—TUBB3—ovarian cancer	0.000249	0.276	CrCbGaD
Vincristine—CYP3A4—Vinorelbine—ovarian cancer	0.000236	0.00148	CbGbCtD
Vincristine—NR0B1—gonad—ovarian cancer	0.000216	0.0162	CbGeAlD
Vincristine—ABCB1—Docetaxel—ovarian cancer	0.0002	0.00125	CbGbCtD
Vincristine—NR0B1—female reproductive system—ovarian cancer	0.000193	0.0145	CbGeAlD
Vincristine—Vinblastine—TUBB3—ovarian cancer	0.000192	0.213	CrCbGaD
Vincristine—TUBA4A—myometrium—ovarian cancer	0.000184	0.0138	CbGeAlD
Vincristine—TUBB1—decidua—ovarian cancer	0.000176	0.0132	CbGeAlD
Vincristine—NR0B1—female gonad—ovarian cancer	0.000176	0.0132	CbGeAlD
Vincristine—RALBP1—myometrium—ovarian cancer	0.000174	0.013	CbGeAlD
Vincristine—TUBB8—testis—ovarian cancer	0.000168	0.0126	CbGeAlD
Vincristine—CYP3A4—Paclitaxel—ovarian cancer	0.000166	0.00104	CbGbCtD
Vincristine—NR0B1—testis—ovarian cancer	0.000156	0.0117	CbGeAlD
Vincristine—ABCB1—Doxorubicin—ovarian cancer	0.000149	0.000933	CbGbCtD
Vincristine—TUBA4A—epithelium—ovarian cancer	0.000145	0.0109	CbGeAlD
Vincristine—TUBA4A—uterine cervix—ovarian cancer	0.000144	0.0108	CbGeAlD
Vincristine—TUBB2B—myometrium—ovarian cancer	0.000143	0.0107	CbGeAlD
Vincristine—TUBB4A—embryo—ovarian cancer	0.000142	0.0107	CbGeAlD
Vincristine—TUBA4A—decidua—ovarian cancer	0.000137	0.0103	CbGeAlD
Vincristine—RALBP1—uterine cervix—ovarian cancer	0.000135	0.0102	CbGeAlD
Vincristine—TUBB—myometrium—ovarian cancer	0.000135	0.0101	CbGeAlD
Vincristine—TUBB2A—myometrium—ovarian cancer	0.000134	0.0101	CbGeAlD
Vincristine—TUBB6—myometrium—ovarian cancer	0.000133	0.00995	CbGeAlD
Vincristine—TUBB1—bone marrow—ovarian cancer	0.000131	0.00981	CbGeAlD
Vincristine—TUBA4A—endometrium—ovarian cancer	0.00013	0.00974	CbGeAlD
Vincristine—RALBP1—decidua—ovarian cancer	0.000129	0.00967	CbGeAlD
Vincristine—RALBP1—endometrium—ovarian cancer	0.000122	0.00918	CbGeAlD
Vincristine—TUBA4A—gonad—ovarian cancer	0.00012	0.00904	CbGeAlD
Vincristine—CYP3A4—Docetaxel—ovarian cancer	0.00012	0.00075	CbGbCtD
Vincristine—TUBA4A—uterus—ovarian cancer	0.00012	0.00898	CbGeAlD
Vincristine—ABCC10—myometrium—ovarian cancer	0.000116	0.00872	CbGeAlD
Vincristine—TUBB4B—myometrium—ovarian cancer	0.000115	0.00865	CbGeAlD
Vincristine—TUBB4A—uterine cervix—ovarian cancer	0.000115	0.00863	CbGeAlD
Vincristine—TUBB3—testis—ovarian cancer	0.000114	0.00858	CbGeAlD
Vincristine—RALBP1—uterus—ovarian cancer	0.000113	0.00846	CbGeAlD
Vincristine—TUBB1—testis—ovarian cancer	0.000112	0.00839	CbGeAlD
Vincristine—TUBB2B—uterine cervix—ovarian cancer	0.000111	0.00834	CbGeAlD
Vincristine—TUBB4B—embryo—ovarian cancer	0.000111	0.00832	CbGeAlD
Vincristine—TUBA4A—female reproductive system—ovarian cancer	0.000108	0.00807	CbGeAlD
Vincristine—TUBB—uterine cervix—ovarian cancer	0.000105	0.0079	CbGeAlD
Vincristine—TUBB2A—uterine cervix—ovarian cancer	0.000105	0.00785	CbGeAlD
Vincristine—TUBB6—epithelium—ovarian cancer	0.000104	0.00781	CbGeAlD
Vincristine—TUBB6—uterine cervix—ovarian cancer	0.000103	0.00775	CbGeAlD
Vincristine—TUBA4A—bone marrow—ovarian cancer	0.000102	0.00762	CbGeAlD
Vincristine—RALBP1—female reproductive system—ovarian cancer	0.000101	0.00761	CbGeAlD
Vincristine—TUBB2B—endometrium—ovarian cancer	0.000101	0.00755	CbGeAlD
Vincristine—TUBB—decidua—ovarian cancer	0.0001	0.00752	CbGeAlD
Vincristine—TUBB2A—decidua—ovarian cancer	9.97e-05	0.00748	CbGeAlD
Vincristine—SLC22A3—myometrium—ovarian cancer	9.94e-05	0.00746	CbGeAlD
Vincristine—TUBB6—decidua—ovarian cancer	9.84e-05	0.00738	CbGeAlD
Vincristine—TUBA4A—female gonad—ovarian cancer	9.79e-05	0.00734	CbGeAlD
Vincristine—TUBA4A—vagina—ovarian cancer	9.73e-05	0.0073	CbGeAlD
Vincristine—TUBB4A—gonad—ovarian cancer	9.65e-05	0.00724	CbGeAlD
Vincristine—TUBB4A—uterus—ovarian cancer	9.59e-05	0.0072	CbGeAlD
Vincristine—RALBP1—bone marrow—ovarian cancer	9.57e-05	0.00718	CbGeAlD
Vincristine—SLC22A3—embryo—ovarian cancer	9.56e-05	0.00717	CbGeAlD
Vincristine—TUBB—endometrium—ovarian cancer	9.52e-05	0.00714	CbGeAlD
Vincristine—TUBB2A—endometrium—ovarian cancer	9.47e-05	0.0071	CbGeAlD
Vincristine—TUBB6—endometrium—ovarian cancer	9.34e-05	0.00701	CbGeAlD
Vincristine—TUBB2B—gonad—ovarian cancer	9.33e-05	0.007	CbGeAlD
Vincristine—RALBP1—female gonad—ovarian cancer	9.22e-05	0.00692	CbGeAlD
Vincristine—RALBP1—vagina—ovarian cancer	9.17e-05	0.00688	CbGeAlD
Vincristine—ABCC10—uterine cervix—ovarian cancer	9.04e-05	0.00678	CbGeAlD
Vincristine—TUBB4B—uterine cervix—ovarian cancer	8.97e-05	0.00673	CbGeAlD
Vincristine—CYP3A4—Doxorubicin—ovarian cancer	8.92e-05	0.000559	CbGbCtD
Vincristine—TUBB—uterus—ovarian cancer	8.77e-05	0.00658	CbGeAlD
Vincristine—TUBB2A—uterus—ovarian cancer	8.72e-05	0.00655	CbGeAlD
Vincristine—TUBA4A—testis—ovarian cancer	8.68e-05	0.00651	CbGeAlD
Vincristine—TUBB6—gonad—ovarian cancer	8.66e-05	0.0065	CbGeAlD
Vincristine—ABCC3—decidua—ovarian cancer	8.65e-05	0.00649	CbGeAlD
Vincristine—ABCB11—testis—ovarian cancer	8.63e-05	0.00648	CbGeAlD
Vincristine—TUBB4A—female reproductive system—ovarian cancer	8.62e-05	0.00647	CbGeAlD
Vincristine—ABCC10—decidua—ovarian cancer	8.61e-05	0.00646	CbGeAlD
Vincristine—TUBB6—uterus—ovarian cancer	8.6e-05	0.00646	CbGeAlD
Vincristine—TUBB4B—decidua—ovarian cancer	8.55e-05	0.00642	CbGeAlD
Vincristine—TUBB2B—female reproductive system—ovarian cancer	8.33e-05	0.00625	CbGeAlD
Vincristine—ABCC1—myometrium—ovarian cancer	8.21e-05	0.00616	CbGeAlD
Vincristine—RALBP1—testis—ovarian cancer	8.18e-05	0.00614	CbGeAlD
Vincristine—ABCC10—endometrium—ovarian cancer	8.17e-05	0.00613	CbGeAlD
Vincristine—TUBB4B—endometrium—ovarian cancer	8.12e-05	0.00609	CbGeAlD
Vincristine—TUBB4A—female gonad—ovarian cancer	7.84e-05	0.00589	CbGeAlD
Vincristine—TUBB2A—female reproductive system—ovarian cancer	7.84e-05	0.00588	CbGeAlD
Vincristine—TUBB6—female reproductive system—ovarian cancer	7.73e-05	0.0058	CbGeAlD
Vincristine—SLC22A3—uterine cervix—ovarian cancer	7.73e-05	0.0058	CbGeAlD
Vincristine—ABCC10—gonad—ovarian cancer	7.58e-05	0.00569	CbGeAlD
Vincristine—TUBB2B—female gonad—ovarian cancer	7.58e-05	0.00569	CbGeAlD
Vincristine—TUBB2B—vagina—ovarian cancer	7.53e-05	0.00565	CbGeAlD
Vincristine—ABCC10—uterus—ovarian cancer	7.53e-05	0.00565	CbGeAlD
Vincristine—TUBB4B—gonad—ovarian cancer	7.53e-05	0.00565	CbGeAlD
Vincristine—TUBB4B—uterus—ovarian cancer	7.48e-05	0.00561	CbGeAlD
Vincristine—TUBB—bone marrow—ovarian cancer	7.44e-05	0.00559	CbGeAlD
Vincristine—TUBB2A—bone marrow—ovarian cancer	7.4e-05	0.00556	CbGeAlD
Vincristine—TUBB6—bone marrow—ovarian cancer	7.3e-05	0.00548	CbGeAlD
Vincristine—TUBB—female gonad—ovarian cancer	7.17e-05	0.00538	CbGeAlD
Vincristine—TUBB2A—female gonad—ovarian cancer	7.14e-05	0.00535	CbGeAlD
Vincristine—TUBB—vagina—ovarian cancer	7.13e-05	0.00535	CbGeAlD
Vincristine—TUBB2A—vagina—ovarian cancer	7.09e-05	0.00532	CbGeAlD
Vincristine—TUBB6—female gonad—ovarian cancer	7.04e-05	0.00528	CbGeAlD
Vincristine—TUBB6—vagina—ovarian cancer	7e-05	0.00525	CbGeAlD
Vincristine—SLC22A3—endometrium—ovarian cancer	6.99e-05	0.00525	CbGeAlD
Vincristine—TUBB4A—testis—ovarian cancer	6.96e-05	0.00522	CbGeAlD
Vincristine—Voacamine—ABCB1—ovarian cancer	6.91e-05	0.0765	CrCbGaD
Vincristine—ABCC3—female reproductive system—ovarian cancer	6.81e-05	0.00511	CbGeAlD
Vincristine—ABCG2—myometrium—ovarian cancer	6.8e-05	0.0051	CbGeAlD
Vincristine—ABCC10—female reproductive system—ovarian cancer	6.77e-05	0.00508	CbGeAlD
Vincristine—TUBB2B—testis—ovarian cancer	6.72e-05	0.00505	CbGeAlD
Vincristine—TUBB4B—female reproductive system—ovarian cancer	6.72e-05	0.00505	CbGeAlD
Vincristine—SLC22A3—gonad—ovarian cancer	6.49e-05	0.00487	CbGeAlD
Vincristine—ABCC10—bone marrow—ovarian cancer	6.39e-05	0.0048	CbGeAlD
Vincristine—ABCC1—uterine cervix—ovarian cancer	6.39e-05	0.0048	CbGeAlD
Vincristine—TUBB—testis—ovarian cancer	6.36e-05	0.00477	CbGeAlD
Vincristine—TUBB4B—bone marrow—ovarian cancer	6.35e-05	0.00476	CbGeAlD
Vincristine—TUBB2A—testis—ovarian cancer	6.33e-05	0.00475	CbGeAlD
Vincristine—TUBA4A—lymph node—ovarian cancer	6.29e-05	0.00472	CbGeAlD
Vincristine—TUBB6—testis—ovarian cancer	6.24e-05	0.00468	CbGeAlD
Vincristine—ABCC3—female gonad—ovarian cancer	6.19e-05	0.00465	CbGeAlD
Vincristine—ABCC10—female gonad—ovarian cancer	6.16e-05	0.00462	CbGeAlD
Vincristine—ABCC10—vagina—ovarian cancer	6.12e-05	0.0046	CbGeAlD
Vincristine—TUBB4B—female gonad—ovarian cancer	6.12e-05	0.00459	CbGeAlD
Vincristine—ABCC1—decidua—ovarian cancer	6.09e-05	0.00457	CbGeAlD
Vincristine—TUBB4B—vagina—ovarian cancer	6.08e-05	0.00456	CbGeAlD
Vincristine—RALBP1—lymph node—ovarian cancer	5.93e-05	0.00445	CbGeAlD
Vincristine—SLC22A3—female reproductive system—ovarian cancer	5.79e-05	0.00435	CbGeAlD
Vincristine—ABCC1—endometrium—ovarian cancer	5.78e-05	0.00434	CbGeAlD
Vincristine—ABCC3—testis—ovarian cancer	5.49e-05	0.00412	CbGeAlD
Vincristine—ABCC10—testis—ovarian cancer	5.47e-05	0.0041	CbGeAlD
Vincristine—ABCC2—female reproductive system—ovarian cancer	5.44e-05	0.00408	CbGeAlD
Vincristine—TUBB4B—testis—ovarian cancer	5.43e-05	0.00407	CbGeAlD
Vincristine—ABCC1—uterus—ovarian cancer	5.33e-05	0.004	CbGeAlD
Vincristine—ABCG2—uterine cervix—ovarian cancer	5.29e-05	0.00397	CbGeAlD
Vincristine—SLC22A3—female gonad—ovarian cancer	5.27e-05	0.00396	CbGeAlD
Vincristine—SLC22A3—vagina—ovarian cancer	5.24e-05	0.00393	CbGeAlD
Vincristine—ABCG2—decidua—ovarian cancer	5.04e-05	0.00378	CbGeAlD
Vincristine—TUBB4A—lymph node—ovarian cancer	5.04e-05	0.00378	CbGeAlD
Vincristine—CYP3A5—uterine cervix—ovarian cancer	4.91e-05	0.00369	CbGeAlD
Vincristine—TUBB2B—lymph node—ovarian cancer	4.87e-05	0.00366	CbGeAlD
Vincristine—ABCG2—endometrium—ovarian cancer	4.79e-05	0.00359	CbGeAlD
Vincristine—SLC22A3—testis—ovarian cancer	4.68e-05	0.00351	CbGeAlD
Vincristine—TUBB—lymph node—ovarian cancer	4.61e-05	0.00346	CbGeAlD
Vincristine—TUBB2A—lymph node—ovarian cancer	4.59e-05	0.00344	CbGeAlD
Vincristine—TUBB6—lymph node—ovarian cancer	4.52e-05	0.0034	CbGeAlD
Vincristine—ABCG2—uterus—ovarian cancer	4.41e-05	0.00331	CbGeAlD
Vincristine—ABCC2—testis—ovarian cancer	4.39e-05	0.00329	CbGeAlD
Vincristine—ABCC1—female gonad—ovarian cancer	4.36e-05	0.00327	CbGeAlD
Vincristine—ABCC1—vagina—ovarian cancer	4.33e-05	0.00325	CbGeAlD
Vincristine—ABCC3—lymph node—ovarian cancer	3.98e-05	0.00299	CbGeAlD
Vincristine—ABCC10—lymph node—ovarian cancer	3.96e-05	0.00297	CbGeAlD
Vincristine—TUBB4B—lymph node—ovarian cancer	3.93e-05	0.00295	CbGeAlD
Vincristine—ABCC1—testis—ovarian cancer	3.87e-05	0.0029	CbGeAlD
Vincristine—ABCG2—bone marrow—ovarian cancer	3.74e-05	0.00281	CbGeAlD
Vincristine—ABCG2—female gonad—ovarian cancer	3.61e-05	0.00271	CbGeAlD
Vincristine—ABCG2—vagina—ovarian cancer	3.59e-05	0.00269	CbGeAlD
Vincristine—SLC22A3—lymph node—ovarian cancer	3.39e-05	0.00254	CbGeAlD
Vincristine—ABCB1—myometrium—ovarian cancer	3.35e-05	0.00252	CbGeAlD
Vincristine—CYP3A5—female gonad—ovarian cancer	3.35e-05	0.00251	CbGeAlD
Vincristine—CYP3A5—vagina—ovarian cancer	3.33e-05	0.0025	CbGeAlD
Vincristine—ABCB1—embryo—ovarian cancer	3.23e-05	0.00242	CbGeAlD
Vincristine—ABCG2—testis—ovarian cancer	3.2e-05	0.0024	CbGeAlD
Vincristine—Vinorelbine—ABCB1—ovarian cancer	3.2e-05	0.0354	CrCbGaD
Vincristine—ABCC2—lymph node—ovarian cancer	3.18e-05	0.00239	CbGeAlD
Vincristine—ABCC1—lymph node—ovarian cancer	2.8e-05	0.0021	CbGeAlD
Vincristine—CYP3A4—female reproductive system—ovarian cancer	2.76e-05	0.00207	CbGeAlD
Vincristine—ABCB1—epithelium—ovarian cancer	2.63e-05	0.00198	CbGeAlD
Vincristine—ABCB1—uterine cervix—ovarian cancer	2.61e-05	0.00196	CbGeAlD
Vincristine—ABCB1—decidua—ovarian cancer	2.49e-05	0.00187	CbGeAlD
Vincristine—Vinblastine—ABCB1—ovarian cancer	2.47e-05	0.0273	CrCbGaD
Vincristine—ABCB1—endometrium—ovarian cancer	2.36e-05	0.00177	CbGeAlD
Vincristine—ABCG2—lymph node—ovarian cancer	2.32e-05	0.00174	CbGeAlD
Vincristine—Mouth ulceration—Doxorubicin—ovarian cancer	2.29e-05	0.000927	CcSEcCtD
Vincristine—Pneumonia—Docetaxel—ovarian cancer	2.28e-05	0.000924	CcSEcCtD
Vincristine—Diarrhoea—Chlorambucil—ovarian cancer	2.28e-05	0.000923	CcSEcCtD
Vincristine—Paraesthesia—Vinorelbine—ovarian cancer	2.28e-05	0.000923	CcSEcCtD
Vincristine—Acute coronary syndrome—Docetaxel—ovarian cancer	2.24e-05	0.000906	CcSEcCtD
Vincristine—Cardiac disorder—Paclitaxel—ovarian cancer	2.23e-05	0.000903	CcSEcCtD
Vincristine—Myocardial infarction—Docetaxel—ovarian cancer	2.23e-05	0.0009	CcSEcCtD
Vincristine—Neuropathy peripheral—Docetaxel—ovarian cancer	2.23e-05	0.0009	CcSEcCtD
Vincristine—Stomatitis—Docetaxel—ovarian cancer	2.21e-05	0.000895	CcSEcCtD
Vincristine—Hepatic failure—Epirubicin—ovarian cancer	2.21e-05	0.000895	CcSEcCtD
Vincristine—Decreased appetite—Vinorelbine—ovarian cancer	2.21e-05	0.000893	CcSEcCtD
Vincristine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	2.19e-05	0.000887	CcSEcCtD
Vincristine—Fatigue—Vinorelbine—ovarian cancer	2.19e-05	0.000886	CcSEcCtD
Vincristine—ABCB1—gonad—ovarian cancer	2.19e-05	0.00164	CbGeAlD
Vincristine—Hypersensitivity—Topotecan—ovarian cancer	2.19e-05	0.000885	CcSEcCtD
Vincristine—Angiopathy—Paclitaxel—ovarian cancer	2.18e-05	0.000883	CcSEcCtD
Vincristine—ABCB1—uterus—ovarian cancer	2.18e-05	0.00163	CbGeAlD
Vincristine—Constipation—Vinorelbine—ovarian cancer	2.17e-05	0.000879	CcSEcCtD
Vincristine—Pain—Vinorelbine—ovarian cancer	2.17e-05	0.000879	CcSEcCtD
Vincristine—Mediastinal disorder—Paclitaxel—ovarian cancer	2.17e-05	0.000877	CcSEcCtD
Vincristine—Hypersensitivity—Melphalan—ovarian cancer	2.14e-05	0.000867	CcSEcCtD
Vincristine—Asthenia—Topotecan—ovarian cancer	2.13e-05	0.000862	CcSEcCtD
Vincristine—Alopecia—Paclitaxel—ovarian cancer	2.13e-05	0.00086	CcSEcCtD
Vincristine—Vomiting—Chlorambucil—ovarian cancer	2.12e-05	0.000858	CcSEcCtD
Vincristine—Mental disorder—Paclitaxel—ovarian cancer	2.11e-05	0.000852	CcSEcCtD
Vincristine—Asthenia—Melphalan—ovarian cancer	2.09e-05	0.000844	CcSEcCtD
Vincristine—Gastrointestinal pain—Vinorelbine—ovarian cancer	2.08e-05	0.00084	CcSEcCtD
Vincristine—Hepatic failure—Doxorubicin—ovarian cancer	2.05e-05	0.000828	CcSEcCtD
Vincristine—Diarrhoea—Topotecan—ovarian cancer	2.03e-05	0.000822	CcSEcCtD
Vincristine—Hypoaesthesia—Docetaxel—ovarian cancer	2.03e-05	0.000821	CcSEcCtD
Vincristine—Back pain—Paclitaxel—ovarian cancer	2.03e-05	0.000819	CcSEcCtD
Vincristine—Urinary tract disorder—Docetaxel—ovarian cancer	2.01e-05	0.000814	CcSEcCtD
Vincristine—Abdominal pain—Vinorelbine—ovarian cancer	2.01e-05	0.000812	CcSEcCtD
Vincristine—Body temperature increased—Vinorelbine—ovarian cancer	2.01e-05	0.000812	CcSEcCtD
Vincristine—Connective tissue disorder—Docetaxel—ovarian cancer	2e-05	0.00081	CcSEcCtD
Vincristine—Urethral disorder—Docetaxel—ovarian cancer	2e-05	0.000808	CcSEcCtD
Vincristine—Hyponatraemia—Epirubicin—ovarian cancer	2e-05	0.000807	CcSEcCtD
Vincristine—Diarrhoea—Melphalan—ovarian cancer	1.99e-05	0.000805	CcSEcCtD
Vincristine—Pain in extremity—Epirubicin—ovarian cancer	1.99e-05	0.000804	CcSEcCtD
Vincristine—Nausea—Chlorambucil—ovarian cancer	1.98e-05	0.000802	CcSEcCtD
Vincristine—Dizziness—Topotecan—ovarian cancer	1.96e-05	0.000794	CcSEcCtD
Vincristine—ABCB1—female reproductive system—ovarian cancer	1.96e-05	0.00147	CbGeAlD
Vincristine—Anaemia—Paclitaxel—ovarian cancer	1.93e-05	0.000783	CcSEcCtD
Vincristine—Agitation—Paclitaxel—ovarian cancer	1.92e-05	0.000778	CcSEcCtD
Vincristine—Cardiac disorder—Docetaxel—ovarian cancer	1.89e-05	0.000765	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—ovarian cancer	1.89e-05	0.000765	CcSEcCtD
Vincristine—Vomiting—Topotecan—ovarian cancer	1.89e-05	0.000764	CcSEcCtD
Vincristine—Vertigo—Paclitaxel—ovarian cancer	1.88e-05	0.000761	CcSEcCtD
Vincristine—Leukopenia—Paclitaxel—ovarian cancer	1.87e-05	0.000758	CcSEcCtD
Vincristine—Rash—Topotecan—ovarian cancer	1.87e-05	0.000757	CcSEcCtD
Vincristine—Hypersensitivity—Vinorelbine—ovarian cancer	1.87e-05	0.000757	CcSEcCtD
Vincristine—Dermatitis—Topotecan—ovarian cancer	1.87e-05	0.000757	CcSEcCtD
Vincristine—Ataxia—Epirubicin—ovarian cancer	1.87e-05	0.000756	CcSEcCtD
Vincristine—Headache—Topotecan—ovarian cancer	1.86e-05	0.000753	CcSEcCtD
Vincristine—Angiopathy—Docetaxel—ovarian cancer	1.85e-05	0.000748	CcSEcCtD
Vincristine—Vomiting—Melphalan—ovarian cancer	1.85e-05	0.000748	CcSEcCtD
Vincristine—Dehydration—Epirubicin—ovarian cancer	1.85e-05	0.000748	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—ovarian cancer	1.85e-05	0.000747	CcSEcCtD
Vincristine—ABCB1—bone marrow—ovarian cancer	1.85e-05	0.00139	CbGeAlD
Vincristine—Pain in extremity—Doxorubicin—ovarian cancer	1.84e-05	0.000744	CcSEcCtD
Vincristine—Mediastinal disorder—Docetaxel—ovarian cancer	1.84e-05	0.000743	CcSEcCtD
Vincristine—Rash—Melphalan—ovarian cancer	1.83e-05	0.000742	CcSEcCtD
Vincristine—Dermatitis—Melphalan—ovarian cancer	1.83e-05	0.000741	CcSEcCtD
Vincristine—Asthenia—Vinorelbine—ovarian cancer	1.82e-05	0.000737	CcSEcCtD
Vincristine—Convulsion—Paclitaxel—ovarian cancer	1.81e-05	0.000734	CcSEcCtD
Vincristine—Hypertension—Paclitaxel—ovarian cancer	1.81e-05	0.000731	CcSEcCtD
Vincristine—Alopecia—Docetaxel—ovarian cancer	1.8e-05	0.000729	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	1.79e-05	0.000724	CcSEcCtD
Vincristine—Mental disorder—Docetaxel—ovarian cancer	1.79e-05	0.000722	CcSEcCtD
Vincristine—Myalgia—Paclitaxel—ovarian cancer	1.78e-05	0.000721	CcSEcCtD
Vincristine—ABCB1—female gonad—ovarian cancer	1.78e-05	0.00134	CbGeAlD
Vincristine—ABCB1—vagina—ovarian cancer	1.77e-05	0.00133	CbGeAlD
Vincristine—Nausea—Topotecan—ovarian cancer	1.76e-05	0.000714	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—ovarian cancer	1.75e-05	0.000709	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—ovarian cancer	1.75e-05	0.000707	CcSEcCtD
Vincristine—Diarrhoea—Vinorelbine—ovarian cancer	1.74e-05	0.000703	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—ovarian cancer	1.73e-05	0.0007	CcSEcCtD
Vincristine—Nausea—Melphalan—ovarian cancer	1.73e-05	0.000699	CcSEcCtD
Vincristine—Back pain—Docetaxel—ovarian cancer	1.72e-05	0.000694	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—ovarian cancer	1.71e-05	0.000692	CcSEcCtD
Vincristine—Anaphylactic shock—Paclitaxel—ovarian cancer	1.71e-05	0.000691	CcSEcCtD
Vincristine—Oedema—Paclitaxel—ovarian cancer	1.71e-05	0.000691	CcSEcCtD
Vincristine—Infection—Paclitaxel—ovarian cancer	1.7e-05	0.000687	CcSEcCtD
Vincristine—Dizziness—Vinorelbine—ovarian cancer	1.68e-05	0.00068	CcSEcCtD
Vincristine—Nervous system disorder—Paclitaxel—ovarian cancer	1.68e-05	0.000678	CcSEcCtD
Vincristine—Thrombocytopenia—Paclitaxel—ovarian cancer	1.67e-05	0.000677	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	1.66e-05	0.00067	CcSEcCtD
Vincristine—Hyperhidrosis—Paclitaxel—ovarian cancer	1.65e-05	0.000668	CcSEcCtD
Vincristine—Anaemia—Docetaxel—ovarian cancer	1.64e-05	0.000663	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—ovarian cancer	1.63e-05	0.00066	CcSEcCtD
Vincristine—Anorexia—Paclitaxel—ovarian cancer	1.63e-05	0.000659	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—ovarian cancer	1.62e-05	0.000656	CcSEcCtD
Vincristine—Vomiting—Vinorelbine—ovarian cancer	1.62e-05	0.000653	CcSEcCtD
Vincristine—Dysuria—Epirubicin—ovarian cancer	1.61e-05	0.00065	CcSEcCtD
Vincristine—Neutropenia—Epirubicin—ovarian cancer	1.61e-05	0.00065	CcSEcCtD
Vincristine—Rash—Vinorelbine—ovarian cancer	1.6e-05	0.000648	CcSEcCtD
Vincristine—Dermatitis—Vinorelbine—ovarian cancer	1.6e-05	0.000647	CcSEcCtD
Vincristine—Hypotension—Paclitaxel—ovarian cancer	1.6e-05	0.000646	CcSEcCtD
Vincristine—Headache—Vinorelbine—ovarian cancer	1.59e-05	0.000644	CcSEcCtD
Vincristine—Leukopenia—Docetaxel—ovarian cancer	1.59e-05	0.000643	CcSEcCtD
Vincristine—ABCB1—testis—ovarian cancer	1.58e-05	0.00118	CbGeAlD
Vincristine—Photosensitivity reaction—Epirubicin—ovarian cancer	1.57e-05	0.000634	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	1.56e-05	0.00063	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—ovarian cancer	1.55e-05	0.000629	CcSEcCtD
Vincristine—Insomnia—Paclitaxel—ovarian cancer	1.55e-05	0.000625	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—ovarian cancer	1.54e-05	0.000623	CcSEcCtD
Vincristine—Convulsion—Docetaxel—ovarian cancer	1.54e-05	0.000622	CcSEcCtD
Vincristine—Paraesthesia—Paclitaxel—ovarian cancer	1.53e-05	0.000621	CcSEcCtD
Vincristine—Hypertension—Docetaxel—ovarian cancer	1.53e-05	0.00062	CcSEcCtD
Vincristine—Myalgia—Docetaxel—ovarian cancer	1.51e-05	0.000611	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—ovarian cancer	1.51e-05	0.000611	CcSEcCtD
Vincristine—Nausea—Vinorelbine—ovarian cancer	1.51e-05	0.00061	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—ovarian cancer	1.5e-05	0.000607	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—ovarian cancer	1.49e-05	0.000604	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—ovarian cancer	1.49e-05	0.000601	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—ovarian cancer	1.49e-05	0.000601	CcSEcCtD
Vincristine—Decreased appetite—Paclitaxel—ovarian cancer	1.49e-05	0.000601	CcSEcCtD
Vincristine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.48e-05	0.000597	CcSEcCtD
Vincristine—Fatigue—Paclitaxel—ovarian cancer	1.47e-05	0.000596	CcSEcCtD
Vincristine—Sweating—Epirubicin—ovarian cancer	1.47e-05	0.000594	CcSEcCtD
Vincristine—Pain—Paclitaxel—ovarian cancer	1.46e-05	0.000591	CcSEcCtD
Vincristine—Constipation—Paclitaxel—ovarian cancer	1.46e-05	0.000591	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—ovarian cancer	1.45e-05	0.000587	CcSEcCtD
Vincristine—Oedema—Docetaxel—ovarian cancer	1.45e-05	0.000586	CcSEcCtD
Vincristine—Anaphylactic shock—Docetaxel—ovarian cancer	1.45e-05	0.000586	CcSEcCtD
Vincristine—Infection—Docetaxel—ovarian cancer	1.44e-05	0.000582	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—ovarian cancer	1.44e-05	0.000582	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—ovarian cancer	1.43e-05	0.000577	CcSEcCtD
Vincristine—Nervous system disorder—Docetaxel—ovarian cancer	1.42e-05	0.000575	CcSEcCtD
Vincristine—Thrombocytopenia—Docetaxel—ovarian cancer	1.42e-05	0.000574	CcSEcCtD
Vincristine—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.4e-05	0.000565	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.39e-05	0.000562	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—ovarian cancer	1.38e-05	0.000559	CcSEcCtD
Vincristine—Anorexia—Docetaxel—ovarian cancer	1.38e-05	0.000558	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—ovarian cancer	1.37e-05	0.000553	CcSEcCtD
Vincristine—Sweating—Doxorubicin—ovarian cancer	1.36e-05	0.00055	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—ovarian cancer	1.36e-05	0.000549	CcSEcCtD
Vincristine—Hypotension—Docetaxel—ovarian cancer	1.35e-05	0.000547	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—ovarian cancer	1.35e-05	0.000547	CcSEcCtD
Vincristine—Abdominal pain—Paclitaxel—ovarian cancer	1.35e-05	0.000546	CcSEcCtD
Vincristine—Body temperature increased—Paclitaxel—ovarian cancer	1.35e-05	0.000546	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—ovarian cancer	1.35e-05	0.000545	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.32e-05	0.000534	CcSEcCtD
Vincristine—Insomnia—Docetaxel—ovarian cancer	1.31e-05	0.00053	CcSEcCtD
Vincristine—Paraesthesia—Docetaxel—ovarian cancer	1.3e-05	0.000526	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—ovarian cancer	1.28e-05	0.000516	CcSEcCtD
Vincristine—Hypoaesthesia—Doxorubicin—ovarian cancer	1.27e-05	0.000512	CcSEcCtD
Vincristine—Decreased appetite—Docetaxel—ovarian cancer	1.26e-05	0.000509	CcSEcCtD
Vincristine—Hypersensitivity—Paclitaxel—ovarian cancer	1.26e-05	0.000509	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—ovarian cancer	1.26e-05	0.000508	CcSEcCtD
Vincristine—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.25e-05	0.000506	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—ovarian cancer	1.25e-05	0.000506	CcSEcCtD
Vincristine—Fatigue—Docetaxel—ovarian cancer	1.25e-05	0.000505	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—ovarian cancer	1.25e-05	0.000505	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—ovarian cancer	1.25e-05	0.000504	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—ovarian cancer	1.24e-05	0.000501	CcSEcCtD
Vincristine—Constipation—Docetaxel—ovarian cancer	1.24e-05	0.000501	CcSEcCtD
Vincristine—Pain—Docetaxel—ovarian cancer	1.24e-05	0.000501	CcSEcCtD
Vincristine—Asthenia—Paclitaxel—ovarian cancer	1.23e-05	0.000496	CcSEcCtD
Vincristine—Alopecia—Epirubicin—ovarian cancer	1.21e-05	0.000492	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—ovarian cancer	1.2e-05	0.000487	CcSEcCtD
Vincristine—Gastrointestinal pain—Docetaxel—ovarian cancer	1.18e-05	0.000479	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—ovarian cancer	1.18e-05	0.000478	CcSEcCtD
Vincristine—Diarrhoea—Paclitaxel—ovarian cancer	1.17e-05	0.000473	CcSEcCtD
Vincristine—Back pain—Epirubicin—ovarian cancer	1.16e-05	0.000468	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—ovarian cancer	1.15e-05	0.000467	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—ovarian cancer	1.15e-05	0.000464	CcSEcCtD
Vincristine—Abdominal pain—Docetaxel—ovarian cancer	1.14e-05	0.000463	CcSEcCtD
Vincristine—Body temperature increased—Docetaxel—ovarian cancer	1.14e-05	0.000463	CcSEcCtD
Vincristine—ABCB1—lymph node—ovarian cancer	1.14e-05	0.000858	CbGeAlD
Vincristine—Dizziness—Paclitaxel—ovarian cancer	1.13e-05	0.000457	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—ovarian cancer	1.12e-05	0.000455	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—ovarian cancer	1.11e-05	0.000451	CcSEcCtD
Vincristine—Anaemia—Epirubicin—ovarian cancer	1.11e-05	0.000448	CcSEcCtD
Vincristine—Agitation—Epirubicin—ovarian cancer	1.1e-05	0.000445	CcSEcCtD
Vincristine—Vomiting—Paclitaxel—ovarian cancer	1.09e-05	0.000439	CcSEcCtD
Vincristine—Rash—Paclitaxel—ovarian cancer	1.08e-05	0.000436	CcSEcCtD
Vincristine—Dermatitis—Paclitaxel—ovarian cancer	1.08e-05	0.000435	CcSEcCtD
Vincristine—Vertigo—Epirubicin—ovarian cancer	1.08e-05	0.000435	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—ovarian cancer	1.07e-05	0.000433	CcSEcCtD
Vincristine—Back pain—Doxorubicin—ovarian cancer	1.07e-05	0.000433	CcSEcCtD
Vincristine—Headache—Paclitaxel—ovarian cancer	1.07e-05	0.000433	CcSEcCtD
Vincristine—Hypersensitivity—Docetaxel—ovarian cancer	1.07e-05	0.000432	CcSEcCtD
Vincristine—Asthenia—Docetaxel—ovarian cancer	1.04e-05	0.00042	CcSEcCtD
Vincristine—Convulsion—Epirubicin—ovarian cancer	1.04e-05	0.00042	CcSEcCtD
Vincristine—Hypertension—Epirubicin—ovarian cancer	1.03e-05	0.000418	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—ovarian cancer	1.02e-05	0.000414	CcSEcCtD
Vincristine—Myalgia—Epirubicin—ovarian cancer	1.02e-05	0.000412	CcSEcCtD
Vincristine—Agitation—Doxorubicin—ovarian cancer	1.02e-05	0.000412	CcSEcCtD
Vincristine—Nausea—Paclitaxel—ovarian cancer	1.01e-05	0.000411	CcSEcCtD
Vincristine—Vertigo—Doxorubicin—ovarian cancer	9.95e-06	0.000403	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—ovarian cancer	9.91e-06	0.000401	CcSEcCtD
Vincristine—Diarrhoea—Docetaxel—ovarian cancer	9.91e-06	0.000401	CcSEcCtD
Vincristine—Oedema—Epirubicin—ovarian cancer	9.77e-06	0.000395	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—ovarian cancer	9.77e-06	0.000395	CcSEcCtD
Vincristine—Infection—Epirubicin—ovarian cancer	9.7e-06	0.000393	CcSEcCtD
Vincristine—Convulsion—Doxorubicin—ovarian cancer	9.6e-06	0.000388	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—ovarian cancer	9.58e-06	0.000388	CcSEcCtD
Vincristine—Dizziness—Docetaxel—ovarian cancer	9.58e-06	0.000387	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—ovarian cancer	9.56e-06	0.000387	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—ovarian cancer	9.56e-06	0.000387	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—ovarian cancer	9.44e-06	0.000382	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—ovarian cancer	9.43e-06	0.000381	CcSEcCtD
Vincristine—Anorexia—Epirubicin—ovarian cancer	9.31e-06	0.000377	CcSEcCtD
Vincristine—Vomiting—Docetaxel—ovarian cancer	9.21e-06	0.000373	CcSEcCtD
Vincristine—Rash—Docetaxel—ovarian cancer	9.13e-06	0.000369	CcSEcCtD
Vincristine—Hypotension—Epirubicin—ovarian cancer	9.13e-06	0.000369	CcSEcCtD
Vincristine—Dermatitis—Docetaxel—ovarian cancer	9.12e-06	0.000369	CcSEcCtD
Vincristine—Headache—Docetaxel—ovarian cancer	9.07e-06	0.000367	CcSEcCtD
Vincristine—Oedema—Doxorubicin—ovarian cancer	9.04e-06	0.000366	CcSEcCtD
Vincristine—Anaphylactic shock—Doxorubicin—ovarian cancer	9.04e-06	0.000366	CcSEcCtD
Vincristine—Infection—Doxorubicin—ovarian cancer	8.98e-06	0.000363	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.9e-06	0.00036	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—ovarian cancer	8.86e-06	0.000359	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—ovarian cancer	8.85e-06	0.000358	CcSEcCtD
Vincristine—Insomnia—Epirubicin—ovarian cancer	8.83e-06	0.000357	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—ovarian cancer	8.77e-06	0.000355	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—ovarian cancer	8.74e-06	0.000353	CcSEcCtD
Vincristine—Anorexia—Doxorubicin—ovarian cancer	8.62e-06	0.000349	CcSEcCtD
Vincristine—Nausea—Docetaxel—ovarian cancer	8.6e-06	0.000348	CcSEcCtD
Vincristine—Decreased appetite—Epirubicin—ovarian cancer	8.49e-06	0.000344	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—ovarian cancer	8.45e-06	0.000342	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.43e-06	0.000341	CcSEcCtD
Vincristine—Fatigue—Epirubicin—ovarian cancer	8.42e-06	0.000341	CcSEcCtD
Vincristine—Constipation—Epirubicin—ovarian cancer	8.35e-06	0.000338	CcSEcCtD
Vincristine—Pain—Epirubicin—ovarian cancer	8.35e-06	0.000338	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.23e-06	0.000333	CcSEcCtD
Vincristine—Insomnia—Doxorubicin—ovarian cancer	8.17e-06	0.000331	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—ovarian cancer	8.12e-06	0.000328	CcSEcCtD
Vincristine—Gastrointestinal pain—Epirubicin—ovarian cancer	7.99e-06	0.000323	CcSEcCtD
Vincristine—Decreased appetite—Doxorubicin—ovarian cancer	7.86e-06	0.000318	CcSEcCtD
Vincristine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.8e-06	0.000316	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—ovarian cancer	7.79e-06	0.000315	CcSEcCtD
Vincristine—Constipation—Doxorubicin—ovarian cancer	7.73e-06	0.000313	CcSEcCtD
Vincristine—Pain—Doxorubicin—ovarian cancer	7.73e-06	0.000313	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—ovarian cancer	7.72e-06	0.000312	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—ovarian cancer	7.72e-06	0.000312	CcSEcCtD
Vincristine—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.39e-06	0.000299	CcSEcCtD
Vincristine—Hypersensitivity—Epirubicin—ovarian cancer	7.2e-06	0.000291	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—ovarian cancer	7.14e-06	0.000289	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—ovarian cancer	7.14e-06	0.000289	CcSEcCtD
Vincristine—Asthenia—Epirubicin—ovarian cancer	7.01e-06	0.000284	CcSEcCtD
Vincristine—Diarrhoea—Epirubicin—ovarian cancer	6.68e-06	0.00027	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—ovarian cancer	6.66e-06	0.000269	CcSEcCtD
Vincristine—Asthenia—Doxorubicin—ovarian cancer	6.48e-06	0.000262	CcSEcCtD
Vincristine—Dizziness—Epirubicin—ovarian cancer	6.46e-06	0.000261	CcSEcCtD
Vincristine—Vomiting—Epirubicin—ovarian cancer	6.21e-06	0.000251	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—ovarian cancer	6.18e-06	0.00025	CcSEcCtD
Vincristine—Rash—Epirubicin—ovarian cancer	6.16e-06	0.000249	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—ovarian cancer	6.15e-06	0.000249	CcSEcCtD
Vincristine—Headache—Epirubicin—ovarian cancer	6.12e-06	0.000248	CcSEcCtD
Vincristine—Dizziness—Doxorubicin—ovarian cancer	5.98e-06	0.000242	CcSEcCtD
Vincristine—Nausea—Epirubicin—ovarian cancer	5.8e-06	0.000235	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—ovarian cancer	5.75e-06	0.000232	CcSEcCtD
Vincristine—Rash—Doxorubicin—ovarian cancer	5.7e-06	0.000231	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—ovarian cancer	5.69e-06	0.00023	CcSEcCtD
Vincristine—Headache—Doxorubicin—ovarian cancer	5.66e-06	0.000229	CcSEcCtD
Vincristine—Nausea—Doxorubicin—ovarian cancer	5.37e-06	0.000217	CcSEcCtD
Vincristine—SLC22A3—Metabolism—FASN—ovarian cancer	2.27e-06	0.000138	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.26e-06	0.000138	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—ovarian cancer	2.26e-06	0.000138	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—SLC5A5—ovarian cancer	2.24e-06	0.000136	CbGpPWpGaD
Vincristine—ABCC1—Disease—EREG—ovarian cancer	2.23e-06	0.000136	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.23e-06	0.000136	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.23e-06	0.000136	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—CTNNB1—ovarian cancer	2.22e-06	0.000135	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—ovarian cancer	2.21e-06	0.000135	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.18e-06	0.000133	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—FASN—ovarian cancer	2.18e-06	0.000133	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—ovarian cancer	2.17e-06	0.000132	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CXCL8—ovarian cancer	2.16e-06	0.000132	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYTB—ovarian cancer	2.16e-06	0.000131	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—SLC2A1—ovarian cancer	2.16e-06	0.000131	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—SLC5A5—ovarian cancer	2.14e-06	0.00013	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.12e-06	0.000129	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MAPK3—ovarian cancer	2.12e-06	0.000129	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—FASN—ovarian cancer	2.09e-06	0.000127	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP1B1—ovarian cancer	2.07e-06	0.000126	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—SLC2A1—ovarian cancer	2.07e-06	0.000126	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—ovarian cancer	2.06e-06	0.000126	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—SLC5A5—ovarian cancer	2.06e-06	0.000125	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.04e-06	0.000124	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.03e-06	0.000123	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—ovarian cancer	2.02e-06	0.000123	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.02e-06	0.000123	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ERBB2—ovarian cancer	2.01e-06	0.000122	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—YAP1—ovarian cancer	2.01e-06	0.000122	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CTNNB1—ovarian cancer	2e-06	0.000121	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MAPK3—ovarian cancer	2e-06	0.000121	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PIK3CB—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MTOR—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP1B1—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—SLC2A1—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—ovarian cancer	1.99e-06	0.000121	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CXCL8—ovarian cancer	1.98e-06	0.00012	CbGpPWpGaD
Vincristine—ABCC1—Disease—FASN—ovarian cancer	1.96e-06	0.000119	CbGpPWpGaD
Vincristine—ABCC1—Disease—PARP1—ovarian cancer	1.95e-06	0.000118	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.94e-06	0.000118	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.94e-06	0.000118	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—ovarian cancer	1.94e-06	0.000118	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—ovarian cancer	1.92e-06	0.000117	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CXCL8—ovarian cancer	1.91e-06	0.000116	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP1B1—ovarian cancer	1.9e-06	0.000116	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MAPK1—ovarian cancer	1.9e-06	0.000115	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.89e-06	0.000115	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.89e-06	0.000115	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN1B—ovarian cancer	1.87e-06	0.000113	CbGpPWpGaD
Vincristine—ABCC1—Disease—SLC2A1—ovarian cancer	1.86e-06	0.000113	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPP2R1A—ovarian cancer	1.84e-06	0.000112	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CASP3—ovarian cancer	1.83e-06	0.000111	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CTNNB1—ovarian cancer	1.83e-06	0.000111	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2—ovarian cancer	1.83e-06	0.000111	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MAPK3—ovarian cancer	1.83e-06	0.000111	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—ovarian cancer	1.78e-06	0.000108	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—ovarian cancer	1.78e-06	0.000108	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—YAP1—ovarian cancer	1.77e-06	0.000107	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CTNNB1—ovarian cancer	1.76e-06	0.000107	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPP2R1A—ovarian cancer	1.76e-06	0.000107	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.76e-06	0.000107	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.75e-06	0.000107	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—YAP1—ovarian cancer	1.75e-06	0.000107	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.75e-06	0.000106	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MAPK1—ovarian cancer	1.74e-06	0.000106	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MMP9—ovarian cancer	1.73e-06	0.000105	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTEN—ovarian cancer	1.72e-06	0.000104	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ABCB1—ovarian cancer	1.71e-06	0.000104	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPP2R1A—ovarian cancer	1.69e-06	0.000103	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.68e-06	0.000102	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TYMS—ovarian cancer	1.67e-06	0.000102	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—FASN—ovarian cancer	1.64e-06	9.95e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.64e-06	9.95e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ABCB1—ovarian cancer	1.63e-06	9.94e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYTB—ovarian cancer	1.63e-06	9.91e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.63e-06	9.9e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.61e-06	9.79e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TYMS—ovarian cancer	1.61e-06	9.76e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.6e-06	9.7e-05	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—ovarian cancer	1.59e-06	9.69e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.58e-06	9.61e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PPP2R1A—ovarian cancer	1.58e-06	9.6e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ABCB1—ovarian cancer	1.57e-06	9.53e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NME2—ovarian cancer	1.56e-06	9.47e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.56e-06	9.46e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.55e-06	9.45e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-06	9.43e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TYMS—ovarian cancer	1.54e-06	9.36e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.54e-06	9.35e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—STAT3—ovarian cancer	1.54e-06	9.34e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—ovarian cancer	1.53e-06	9.32e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.52e-06	9.26e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.5e-06	9.12e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.49e-06	9.07e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-06	8.92e-05	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—ovarian cancer	1.46e-06	8.86e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—FASN—ovarian cancer	1.44e-06	8.76e-05	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—ovarian cancer	1.43e-06	8.7e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—FASN—ovarian cancer	1.43e-06	8.68e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—ovarian cancer	1.43e-06	8.68e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.42e-06	8.66e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.42e-06	8.66e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.42e-06	8.62e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.4e-06	8.54e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK1—ovarian cancer	1.4e-06	8.49e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—ovarian cancer	1.4e-06	8.49e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.37e-06	8.32e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.36e-06	8.25e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.35e-06	8.23e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CAV1—ovarian cancer	1.35e-06	8.2e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.32e-06	8.04e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—ovarian cancer	1.32e-06	8.02e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.32e-06	8e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.31e-06	7.98e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.3e-06	7.91e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CAV1—ovarian cancer	1.29e-06	7.87e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.28e-06	7.79e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—YAP1—ovarian cancer	1.27e-06	7.7e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TERT—ovarian cancer	1.25e-06	7.63e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.25e-06	7.58e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CAV1—ovarian cancer	1.24e-06	7.54e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.24e-06	7.51e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CG—ovarian cancer	1.23e-06	7.47e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ABCB1—ovarian cancer	1.23e-06	7.47e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.22e-06	7.41e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.22e-06	7.41e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-06	7.37e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TYMS—ovarian cancer	1.21e-06	7.33e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.19e-06	7.2e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CG—ovarian cancer	1.18e-06	7.16e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—ovarian cancer	1.17e-06	7.13e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.16e-06	7.08e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CAV1—ovarian cancer	1.16e-06	7.06e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.15e-06	7.01e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.15e-06	7e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CG—ovarian cancer	1.13e-06	6.87e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—ovarian cancer	1.12e-06	6.82e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6ST—ovarian cancer	1.1e-06	6.69e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ABCB1—ovarian cancer	1.08e-06	6.57e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CD—ovarian cancer	1.08e-06	6.57e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—ovarian cancer	1.07e-06	6.52e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.07e-06	6.51e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TYMS—ovarian cancer	1.06e-06	6.45e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.06e-06	6.43e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—APC—ovarian cancer	1.06e-06	6.43e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TYMS—ovarian cancer	1.05e-06	6.4e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CD—ovarian cancer	1.04e-06	6.3e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—FASN—ovarian cancer	1.03e-06	6.28e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.02e-06	6.22e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.02e-06	6.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYTB—ovarian cancer	1e-06	6.11e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CD—ovarian cancer	9.93e-07	6.04e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—ovarian cancer	9.9e-07	6.02e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	9.81e-07	5.96e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CAV1—ovarian cancer	9.72e-07	5.91e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—YAP1—ovarian cancer	9.56e-07	5.81e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CB—ovarian cancer	9.42e-07	5.73e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	9.4e-07	5.72e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CD—ovarian cancer	9.29e-07	5.65e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.29e-07	5.65e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CB—ovarian cancer	9.03e-07	5.49e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CG—ovarian cancer	8.85e-07	5.38e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	8.78e-07	5.34e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—BRIP1—ovarian cancer	8.78e-07	5.34e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CB—ovarian cancer	8.66e-07	5.26e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.64e-07	5.25e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CAV1—ovarian cancer	8.55e-07	5.2e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CAV1—ovarian cancer	8.48e-07	5.15e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	8.34e-07	5.07e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERBB2—ovarian cancer	8.21e-07	4.99e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTEN—ovarian cancer	8.14e-07	4.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MTOR—ovarian cancer	8.1e-07	4.92e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CB—ovarian cancer	8.1e-07	4.92e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTEN—ovarian cancer	7.8e-07	4.74e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CG—ovarian cancer	7.79e-07	4.74e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—FASN—ovarian cancer	7.79e-07	4.74e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CD—ovarian cancer	7.78e-07	4.73e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ABCB1—ovarian cancer	7.74e-07	4.71e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	7.72e-07	4.69e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.66e-07	4.66e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TYMS—ovarian cancer	7.6e-07	4.62e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1B—ovarian cancer	7.6e-07	4.62e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTEN—ovarian cancer	7.48e-07	4.55e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.4e-07	4.5e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CTNNB1—ovarian cancer	7.18e-07	4.37e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.09e-07	4.31e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTEN—ovarian cancer	7e-07	4.26e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.85e-07	4.16e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	6.79e-07	4.13e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CB—ovarian cancer	6.78e-07	4.12e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.29e-07	3.83e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—STAT3—ovarian cancer	6.26e-07	3.81e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—ovarian cancer	6.24e-07	3.8e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CAV1—ovarian cancer	6.13e-07	3.73e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK3—ovarian cancer	5.98e-07	3.64e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.97e-07	3.63e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	5.92e-07	3.6e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—YAP1—ovarian cancer	5.89e-07	3.58e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTEN—ovarian cancer	5.86e-07	3.56e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—ovarian cancer	5.82e-07	3.54e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CA—ovarian cancer	5.74e-07	3.49e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TYMS—ovarian cancer	5.74e-07	3.49e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK1—ovarian cancer	5.69e-07	3.46e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—ovarian cancer	5.69e-07	3.46e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.58e-07	3.39e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CA—ovarian cancer	5.5e-07	3.35e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—ovarian cancer	5.37e-07	3.27e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CA—ovarian cancer	5.28e-07	3.21e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTEN—ovarian cancer	5.16e-07	3.14e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTEN—ovarian cancer	5.11e-07	3.11e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CA—ovarian cancer	4.94e-07	3e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.91e-07	2.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—FASN—ovarian cancer	4.8e-07	2.92e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.72e-07	2.87e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—ovarian cancer	4.69e-07	2.85e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CAV1—ovarian cancer	4.62e-07	2.81e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—ovarian cancer	4.57e-07	2.78e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.56e-07	2.77e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—ovarian cancer	4.5e-07	2.73e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—ovarian cancer	4.37e-07	2.66e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.37e-07	2.66e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—ovarian cancer	4.31e-07	2.62e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.28e-07	2.6e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.21e-07	2.56e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CA—ovarian cancer	4.14e-07	2.51e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—ovarian cancer	4.03e-07	2.45e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.88e-07	2.36e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.7e-07	2.25e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTEN—ovarian cancer	3.7e-07	2.25e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.64e-07	2.21e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.61e-07	2.19e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.6e-07	2.19e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.54e-07	2.15e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—ovarian cancer	3.38e-07	2.05e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.23e-07	1.96e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—ovarian cancer	2.97e-07	1.81e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.95e-07	1.79e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.85e-07	1.73e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTEN—ovarian cancer	2.79e-07	1.7e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.61e-07	1.59e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.59e-07	1.58e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.28e-07	1.39e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—ovarian cancer	2.13e-07	1.29e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.99e-07	1.21e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.97e-07	1.2e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.72e-07	1.04e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—ovarian cancer	1.61e-07	9.77e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.21e-07	7.37e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—ovarian cancer	9.9e-08	6.02e-06	CbGpPWpGaD
